Abstract:5182 Bcl-2 family of proteins are over-expressed in many cancers including leukemia and lymphoma, and it’s now recognized that overexpression of Bcl-2 family proteins plays an important role in the resistance to current anti-cancer therapies and is associated with unfavorable outcome. Gossypol is a polyphenolic aldehyde occurring naturally in cottonseed that has been extensively investigated as a male contraceptive agent, was recently discovered as a potent pan inhibitor of Bcl-2 family proteins. To overcome the potential non-specific toxicity related to the two reactive aldehyde groups in gossypol, we designed and synthesized a novel apogossypolone (ApoG2) in which the two aldehyde groups of gossypol are completely removed. We showed previously that ApoG2 exhibited more potent binding to Bcl-2 proteins, with Ki value of 25 nM for Mcl-1, Ki value of 35 nM for Bcl-2, respectively. In this study, we compared the stability, tolerance and antiproliferation effects in four human leukemia and lymphoma cells (HL-60, U937, K562, and Raji). Each sample of stability tests was evaluated for spectral purity using a proposed HPLC method and an HPLC system equipped with UV detector. The results showed that ApoG2 is very stable in the solid states upon standing at room temperatures for at least three weeks, and in various vehicles such as CMC (carboxymethylcellulose), DMSO and sesame oil. More importantly, when gossypols and ApoG2 were subjected to stress conditions of acid, base, peroxide and light, ApoG2 is the only stable compound resistant to acid, base, peroxide and light among gossypol and gossypol derivatives. The cytotoxicity was assessed in cell cultures derived from leukaemia and lymphoma using the tetrazolium-based WST viability assay. ApoG2 induced a dose-dependent cell killing effect in all cell lines with a mean IC50 of 1-3 μM at 72 hours and was significantly more potent than the racemic gossypol. In vitro, ApoG2 also demonstrated strong synergy with various kinase inhibitors in multiple cancer cell lines. Furthermore, ApoG2 was investigated in both mice and rats for maximal tolerated dose (MTD), and the data indicate that ApoG2 was significantly more tolerable than gossypol with MTD dose at more than 2,000 mg/kg level in a multi-dosing schedule. Preliminary studies using one gastric cancer xenograft model showed that ApoG2 is orally active against tumor proliferation in vivo. These investigations suggest that a novel and potent derivative of gossypol without aldehyde functional groups such as ApoG2 may have therapeutic potential for human leukemia/lymphoma and solid tumors either as a single agent or in a combination regimen.

A novel bioavailable BH3 mimetic efficiently inhibits colon cancer via cascade effects of mitochondria.

Natural BH3 Mimetic (-)-gossypol Chemosensitizes Human Prostate Cancer Via Bcl-xL Inhibition Accompanied by Increase of Puma and Noxa

In Vitro Effects of the BH3 Mimetic, (−)-Gossypol, on Head and Neck Squamous Cell Carcinoma Cells

A Novel Water-Soluble Gossypol Derivative Increases Chemotherapeutic Sensitivity and Promotes Growth Inhibition in Colon Cancer

The Bcl-2 Homology Domain 3 Mimetic Gossypol Induces Both Beclin 1-Dependent And Beclin 1-Independent Cytoprotective Autophagy In Cancer Cells

Synergistic cytotoxicity of Bcl-xL inhibitor, gossypol and chemotherapeutic agents in non-Hodgkin’s lymphoma cells

Design, Synthesis and Evaluation of Novel Apogossypol Derivatives Targeting Anti-Apoptotic Bcl-2 Family Proteins

Gossypol with Hydrophobic Linear Esters Exhibits Enhanced Antitumor Activity As an Inhibitor of Antiapoptotic Proteins.

A Novel Pan Inhibitor of Bcl-2 and Mcl-1 Apogossypolone (apog2) with Superior Stability and Improved Activity Against Human Leukemia and Lymphoma Cells.

Synthesis and Biological Evaluation of a Novel Apogossypolone Derivative

Gossypol induces apoptosis of human pancreatic cancer cells via CHOP/endoplasmic reticulum stress signaling pathway

A Randomized, Double-Blind, Placebo-Controlled Study of B-cell Lymphoma 2 Homology 3 Mimetic Gossypol Combined with Docetaxel and Cisplatin for Advanced Non-Small Cell Lung Cancer with High Expression of Apurinic/apyrimidinic Endonuclease 1

The Novel Bh-3 Mimetic Apogossypolone Induces Beclin-1-And Ros-Mediated Autophagy in Human Hepatocellular Cells

Gossypol Has Anti-Cancer Effects by Dual Targeting Mdm2 and Vegf in Human Breast Cancer

A novel small-molecule YLT205 induces apoptosis in human colorectal cells via mitochondrial apoptosis pathway in vitro and inhibits tumor growth in vivo.

Blockade of CaV3 calcium channels and induction of G0/G1 cell cycle arrest in colon cancer cells by gossypol

(-)-Gossypol Suppresses the Growth of Human Prostate Cancer Xenografts Via Modulating Vegf Signaling-Mediated Angiogenesis

A novel camptothecin derivative, ZBH-01, exhibits superior antitumor efficacy than irinotecan by regulating the cell cycle

The BH3 mimetic (±) gossypol induces ROS-independent apoptosis and mitochondrial dysfunction in human A375 melanoma cells in vitro

Ginkgolide C promotes apoptosis and abrogates metastasis of colorectal carcinoma cells by targeting Wnt/β-catenin signaling pathway

Molecular Mechanism of Gossypol-Induced Cell Growth Inhibition and Cell Death of HT-29 Human Colon Carcinoma Cells.